Sincalide Patent Expiration

Sincalide was first introduced by Bracco Diagnostics Inc in its drug Kinevac on Approved Prior to Jan 1, 1982. Another drug containing Sincalide is Sincalide. 2 different companies have introduced drugs containing Sincalide.


Sincalide Patents

Given below is the list of patents protecting Sincalide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Sincalide US11110063 Storage stable sincalide formulations Apr 20, 2038 Maia Pharms Inc
Sincalide US11318100 Storage stable sincalide formulations Apr 20, 2038 Maia Pharms Inc
Sincalide US11737983 Storage stable sincalide formulations Apr 20, 2038 Maia Pharms Inc
Kinevac US6803046 Sincalide formulations Aug 16, 2022

(Expired)

Bracco



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Sincalide's patents.

Given below is the list recent legal activities going on the following patents of Sincalide.

Activity Date Patent Number
Patent litigations
Email Notification 29 Aug, 2023 US11737983
Patent eGrant Notification 29 Aug, 2023 US11737983
Recordation of Patent eGrant 29 Aug, 2023 US11737983
Patent Issue Date Used in PTA Calculation 29 Aug, 2023 US11737983
Mail Patent eGrant Notification 29 Aug, 2023 US11737983
Recordation of Patent Grant Mailed 29 Aug, 2023 US11737983
Electronic Review 10 Aug, 2023 US11737983
Email Notification 10 Aug, 2023 US11737983
Issue Notification Mailed 09 Aug, 2023 US11737983
Application Is Considered Ready for Issue 14 Jul, 2023 US11737983


Sincalide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List